Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study

BACKGROUND: To describe changes in health-related quality of life (HRQoL) of postmenopausal women with osteoporosis treated with teriparatide for up to 18 months and followed-up for a further 18 months, and to assess the influence of recent prior and incident fractures. METHODS: The European Forsteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljunggren, Östen, Barrett, Annabel, Stoykov, Ivaylo, Langdahl, Bente L, Lems, Willem F, Walsh, J Bernard, Fahrleitner-Pammer, Astrid, Rajzbaum, Gerald, Jakob, Franz, Karras, Dimitrios, Marin, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765934/
https://www.ncbi.nlm.nih.gov/pubmed/23968239
http://dx.doi.org/10.1186/1471-2474-14-251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765934/
https://www.ncbi.nlm.nih.gov/pubmed/23968239
http://dx.doi.org/10.1186/1471-2474-14-251

Ejemplares similares